Mavatar

We make biology actionable

Mavatar builds digital disease models that reveal how diseases work, so researchers, pharma teams and clinicians can make decisions based on biology.

Who we are

Biological intelligence for drug development and treatment selection

Mavatar builds digital disease models that integrate and interpret large-scale biomedical data to reveal how diseases work. Our technology is powered by DINA (Deep Integrated Network Analysis), a framework developed from more than 20 years of biomedical research. By connecting molecular data across diseases, tissues and biological systems, our models give a systems-level view of disease that individual datasets can’t show on their own. We apply this across drug development and treatment selection. Through Mavatar Discovery and our Pharma Services, we help research and pharmaceutical teams explore disease biology, build hypotheses and answer complex R&D questions. We are also developing Mavatar Precision, a clinical decision support tool designed to inform treatment selection based on each patient’s biology.

  • 20 years of research
  • DINA framework
  • Medical Avatars

Our mission

To treat disease better, we first need to understand it better

Our mission is to transform how we understand and treat human disease, and to make precision medicine a reality for everyone. A data-driven understanding of human biology can improve R&D decisions today, and ultimately the decisions made in patient care.

Our culture

Curious, rigorous, and open

Mavatar brings together specialists in computational biology, bioinformatics, data science and clinical research. We work across disciplines, because complex disease questions need many perspectives. We value openness and curiosity, combine rigorous science with creative problem-solving, and encourage everyone to question assumptions, including our own.

OUR LEADERSHIP TEAM

The people behind Mavatar

Meet the people behind Mavatar. We’re scientists, clinicians, engineers and business builders who share one belief: that patients deserve treatments chosen for their biology, not for the average. Some of us have spent decades studying disease in the lab, others have helped bring new diagnostics and therapies to patients. What we have in common is curiosity, a healthy respect for the data, and the conviction that the answers are often already there, waiting to be understood.

Johan Juhlin, CEO

Chief Executive Officer & Co-Founder

Johan Juhlin

Johan leads Mavatar’s strategy and growth as co-founder and CEO, with over 25 years in the medical field and senior roles in pharma and diagnostics. Before Mavatar, he helped lead the launch of HER2 testing for breast cancer at Ventana Medical, reaching 94% adoption within two years by bringing together diagnostics, therapy, pathologists, pharma and laboratories.

Fredrik Barrenäs, CTO

Chief Technology Officer & Co-Founder

Fredrik Barrenäs, PhD

Fredrik leads Mavatar’s technology as co-founder and CTO, owning the architecture behind Mavatar Discovery and the DINA framework that powers the company’s platforms. A bioinformatics researcher by background, his work spans immunology, disease mechanisms and pharmaceutics, with a focus on uncovering new biological insights through data-driven research.

Danuta Gawel, CRDO

Chief Research and Development Officer & Co-Founder

Danuta Gawel, PhD

Danuta leads Mavatar’s research and development as co-founder and Chief R&D Officer, building the machine learning-driven technology behind its digital disease models. She holds a PhD in Medical Science from the Centre for Personalized Medicine at Linköping University, with a background in biotechnology and bioinformatics focused on translating molecular insights into clinical applications.

Daniel Nilsson, CFO

Chief Financial Officer / Legal & Co-Founder

Daniel Nilsson

Daniel leads Mavatar’s finance and legal affairs as co-founder and CFO, and heads up the company’s US expansion from the San Diego office. He brings 20 years of experience in the legal profession, focusing on transactions, agreements and privacy for technology companies.

Linda Wakeham, CMCO

Chief Marketing & Communications Officer

Linda Wakeham

Linda leads Mavatar’s brand and communication, with over 25 years of experience across technology, healthcare and finance, much of it in startups and scale-ups with international exposure. Before Mavatar, she was Head of PR & Communications at Kronans Apotek, one of the largest pharmacy chains in Sweden.

Our offices

  • Stockholm, Sweden

    Mavatar ABBarnhusgatan 20111 23 Stockholm, Sweden
  • Helsingborg, Sweden

    Mavatar ABVasatorpsvägen 3254 57 Helsingborg
  • San Diego, CA, USA

    Mavatar Inc.4660 La Jolla Village DriveSan Diego, CA 92122

Understanding disease is a team effort

We work with researchers, pharma teams, clinicians and partners who share our goal of treating disease better, starting with understanding it better.